Stay updated on Pembrolizumab for T/NK-cell Lymphomas Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for T/NK-cell Lymphomas Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for T/NK-cell Lymphomas Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The clinical trial record for pembrolizumab in relapsed or refractory T/NK-cell lymphomas is now displayed, including its eligibility criteria, treatment plan, outcome measures, contacts, and study dates.
    Difference
    46%
    Check dated 2026-11-08T05:13:06.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The page remains a 403 Forbidden error rather than showing the clinical study record. The footer revision label changes from v3.7.2 to v3.8.0.
    Difference
    0.2%
    Check dated 2026-11-01T02:00:43.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    A site-wide NIH announcement about the transition from “Artificial Intelligence” to “Super Intelligence” appears above the unavailable study record.
    Difference
    1%
    Check dated 2026-10-25T02:04:55.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The footer revision identifier advances from v3.7.1 to v3.7.2 while the page remains a 403 Forbidden error screen.
    Difference
    0.2%
    Check dated 2026-10-18T01:47:31.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The site footer revision label changes from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-11T02:27:54.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The study-record page displays a 403 Forbidden message and a Home link instead of the clinical-trial details.
    Difference
    0.5%
    Check dated 2026-10-04T02:01:16.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for T/NK-cell Lymphomas Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for T/NK-cell Lymphomas Clinical Trial page.